Early Phase & PK Studies

Evidentis conducts early phase clinical research designed to understand how investigational therapies behave in the body. These studies evaluate pharmacokinetics (PK), safety, tolerability and dose-related characteristics that inform later-stage development. Our dedicated research suite supports controlled sampling windows, timed procedures and short-stay protocols.

Study Types We Support

Phase 1b studies

Pharmacokinetic (PK) studies

Dose-finding and dose-escalation studies

Controlled sampling protocols

Short-stay or timed-visit protocols

Early mechanistic or biomarker-focused studies

What Participation May Involve

Depending on the protocol, participation may include:

Timed blood draws

Clinic visits

Short-stay observation periods

Laboratory testing

PK/PD sampling workflows

Questionnaires or symptom assessments

There is no cost to participate. Eligible participants may receive compensation for study-related time and travel.

Confidentiality

All information provided during screening is confidential and used only to determine potential eligibility for clinical research participation.